Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 142

1.

Survival benefit with radium-223 dichloride in a mouse model of breast cancer bone metastasis.

Suominen MI, Rissanen JP, Käkönen R, Fagerlund KM, Alhoniemi E, Mumberg D, Ziegelbauer K, Halleen JM, Käkönen SM, Scholz A.

J Natl Cancer Inst. 2013 Jun 19;105(12):908-16. doi: 10.1093/jnci/djt116. Epub 2013 May 16.

PMID:
23682134
[PubMed - indexed for MEDLINE]
Free Article
2.

Antitumor effects of clinical dosing regimens of bisphosphonates in experimental breast cancer bone metastasis.

Daubiné F, Le Gall C, Gasser J, Green J, Clézardin P.

J Natl Cancer Inst. 2007 Feb 21;99(4):322-30.

PMID:
17312309
[PubMed - indexed for MEDLINE]
Free Article
3.

Death receptor 5 agonist TRA8 in combination with the bisphosphonate zoledronic acid attenuated the growth of breast cancer metastasis.

Szafran AA, Folks K, Warram J, Chanda D, Wang D, Zinn KR.

Cancer Biol Ther. 2009 Jun;8(12):1109-16.

PMID:
19652526
[PubMed - indexed for MEDLINE]
Free Article
4.

Anticancer mechanisms of doxorubicin and zoledronic acid in breast cancer tumor growth in bone.

Ottewell PD, Woodward JK, Lefley DV, Evans CA, Coleman RE, Holen I.

Mol Cancer Ther. 2009 Oct;8(10):2821-32. doi: 10.1158/1535-7163.MCT-09-0462. Epub 2009 Sep 29.

PMID:
19789217
[PubMed - indexed for MEDLINE]
Free Article
5.

Antitumor effects of doxorubicin followed by zoledronic acid in a mouse model of breast cancer.

Ottewell PD, Mönkkönen H, Jones M, Lefley DV, Coleman RE, Holen I.

J Natl Cancer Inst. 2008 Aug 20;100(16):1167-78. doi: 10.1093/jnci/djn240. Epub 2008 Aug 11.

PMID:
18695136
[PubMed - indexed for MEDLINE]
Free Article
6.

Effect of combination therapy with a novel bisphosphonate, minodronate (YM529), and docetaxel on a model of bone metastasis by human transitional cell carcinoma.

Inoue K, Karashima T, Fukata S, Nomura A, Kawada C, Kurabayashi A, Furihata M, Ohtsuki Y, Shuin T.

Clin Cancer Res. 2005 Sep 15;11(18):6669-77.

PMID:
16166446
[PubMed - indexed for MEDLINE]
Free Article
7.

Differential effect of doxorubicin and zoledronic acid on intraosseous versus extraosseous breast tumor growth in vivo.

Ottewell PD, Deux B, Mönkkönen H, Cross S, Coleman RE, Clezardin P, Holen I.

Clin Cancer Res. 2008 Jul 15;14(14):4658-66. doi: 10.1158/1078-0432.CCR-07-1545.

PMID:
18628481
[PubMed - indexed for MEDLINE]
Free Article
8.

Radium Ra 223 dichloride in castration-resistant prostate cancer.

Joung JY, Ha YS, Kim IY.

Drugs Today (Barc). 2013 Aug;49(8):483-90. doi: 10.1358/dot.2013.49.8.1968670.

PMID:
23977665
[PubMed - indexed for MEDLINE]
9.

The activity of zoledronic Acid on neuroblastoma bone metastasis involves inhibition of osteoclasts and tumor cell survival and proliferation.

Peng H, Sohara Y, Moats RA, Nelson MD Jr, Groshen SG, Ye W, Reynolds CP, DeClerck YA.

Cancer Res. 2007 Oct 1;67(19):9346-55.

PMID:
17909043
[PubMed - indexed for MEDLINE]
Free Article
10.

Effect of zoledronic acid on the doxycycline-induced decrease in tumour burden in a bone metastasis model of human breast cancer.

Duivenvoorden WC, Vukmirović-Popović S, Kalina M, Seidlitz E, Singh G.

Br J Cancer. 2007 May 21;96(10):1526-31. Epub 2007 Apr 17.

PMID:
17437017
[PubMed - indexed for MEDLINE]
Free PMC Article
11.

Antagonism of inhibitor of apoptosis proteins increases bone metastasis via unexpected osteoclast activation.

Yang C, Davis JL, Zeng R, Vora P, Su X, Collins LI, Vangveravong S, Mach RH, Piwnica-Worms D, Weilbaecher KN, Faccio R, Novack DV.

Cancer Discov. 2013 Feb;3(2):212-23. doi: 10.1158/2159-8290.CD-12-0271. Epub 2012 Dec 26.

PMID:
23269702
[PubMed - indexed for MEDLINE]
Free PMC Article
12.

Bisphosphonates for breast cancer.

Pavlakis N, Schmidt R, Stockler M.

Cochrane Database Syst Rev. 2005 Jul 20;(3):CD003474. Review. Update in: Cochrane Database Syst Rev. 2012;2:CD003474.

PMID:
16034900
[PubMed - indexed for MEDLINE]
13.

Plumbagin inhibits breast tumor bone metastasis and osteolysis by modulating the tumor-bone microenvironment.

Li Z, Xiao J, Wu X, Li W, Yang Z, Xie J, Xu L, Cai X, Lin Z, Guo W, Luo J, Liu M.

Curr Mol Med. 2012 Sep;12(8):967-81.

PMID:
22574935
[PubMed - indexed for MEDLINE]
14.

Effects of oral UFT combined with or without zoledronic acid on bone metastasis in the 4T1/luc mouse breast cancer.

Hiraga T, Ueda A, Tamura D, Hata K, Ikeda F, Williams PJ, Yoneda T.

Int J Cancer. 2003 Oct 10;106(6):973-9.

PMID:
12918079
[PubMed - indexed for MEDLINE]
15.

RANKL inhibition combined with tamoxifen treatment increases anti-tumor efficacy and prevents tumor-induced bone destruction in an estrogen receptor-positive breast cancer bone metastasis model.

Canon J, Bryant R, Roudier M, Branstetter DG, Dougall WC.

Breast Cancer Res Treat. 2012 Oct;135(3):771-80. doi: 10.1007/s10549-012-2222-2. Epub 2012 Aug 29.

PMID:
22926264
[PubMed - indexed for MEDLINE]
16.

The bisphosphonate ibandronate promotes apoptosis in MDA-MB-231 human breast cancer cells in bone metastases.

Hiraga T, Williams PJ, Mundy GR, Yoneda T.

Cancer Res. 2001 Jun 1;61(11):4418-24.

PMID:
11389070
[PubMed - indexed for MEDLINE]
Free Article
17.

Synergistic inhibitory activity of zoledronate and paclitaxel on bone metastasis in nude mice.

Lu S, Zhang J, Zhou Z, Liao ML, He WZ, Zhou XY, Li ZM, Xiang JQ, Wang JJ, Chen HQ.

Oncol Rep. 2008 Sep;20(3):581-7.

PMID:
18695909
[PubMed - indexed for MEDLINE]
18.

Zoledronic acid decreased osteolysis but not bone metastasis in a nude mouse model of canine prostate cancer with mixed bone lesions.

Thudi NK, Martin CK, Nadella MV, Fernandez SA, Werbeck JL, Pinzone JJ, Rosol TJ.

Prostate. 2008 Jul 1;68(10):1116-25. doi: 10.1002/pros.20776.

PMID:
18461562
[PubMed - indexed for MEDLINE]
Free PMC Article
19.

Angiogenesis inhibitor TNP-470 inhibits human breast cancer osteolytic bone metastasis in nude mice through the reduction of bone resorption.

Sasaki A, Alcalde RE, Nishiyama A, Lim DD, Mese H, Akedo H, Matsumura T.

Cancer Res. 1998 Feb 1;58(3):462-7.

PMID:
9458090
[PubMed - indexed for MEDLINE]
Free Article
20.

Matrix metalloproteinase activity, bone matrix turnover, and tumor cell proliferation in prostate cancer bone metastasis.

Nemeth JA, Yousif R, Herzog M, Che M, Upadhyay J, Shekarriz B, Bhagat S, Mullins C, Fridman R, Cher ML.

J Natl Cancer Inst. 2002 Jan 2;94(1):17-25.

PMID:
11773278
[PubMed - indexed for MEDLINE]
Free Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk